Breaking News
Get 55% Off 0
Get Premium Data for Cyber Monday: Up to 55% Off InvestingPro
CLAIM SALE
Close

Bristol-Myers Squibb Company BDR (BMYB34)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
353.08 +0.00    +0.00%
06/12 - Delayed Data. Currency in BRL
  • Volume: 0
  • Bid/Ask: 353.42 / 400.00
  • Day's Range: 346.85 - 353.50
Type:  Equity
Market:  Brazil
ISIN:  BRBMYBBDR000 
Bristol Myers Squibb Company BDR 353.08 +0.00 +0.00%

BMYB34 Financial Summary

 
A brief financial summary of Bristol-Myers Squibb Company BDR as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Bristol-Myers Squibb Company reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was USD 409 million compared to USD 321 million a year ago. Revenue was USD 11,892 million compared to USD 10,966 million a year ago. Net income was USD 1,211 million compared to USD 1,928 million a year ago. Basic earnings per share from continuing operations was USD 0.6 compared to USD 0.94 a year ago. Diluted earnings per share from continuing operations was USD 0.6 compared to USD 0.93 a year ago. For the nine months, sales was USD 991 million compared to USD 919 million a year ago. Revenue was USD 35,958 million compared to USD 33,529 million a year ago. Net loss was USD 9,020 million compared to net income of USD 6,263 million a year ago. Basic loss per share from continuing operations was USD 4.45 compared to basic earnings per share from continuing operations of USD 3.01 a year ago. Diluted loss per share from continuing operations was USD 4.45 compared to diluted earnings per share from continuing operations of USD 2.99 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BMYB34 Income Statement

Gross margin TTM 75.87%
Operating margin TTM 18.95%
Net Profit margin TTM -15.3%
Return on Investment TTM 10.89%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 11892 12201 11865 11477
Gross Profit 9036 9230 8955 8770
Operating Income 2197 2598 2284 1952
Net Income 1211 1680 -11911 1762

BMYB34 Balance Sheet

Quick Ratio MRQ 0.86
Current Ratio MRQ 1.24
LT Debt to Equity MRQ 284.16%
Total Debt to Equity MRQ 300.06%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 93670 94646 99031 95159
Total Liabilities 76470 77577 82483 65674
Total Equity 17200 17069 16548 29485

BMYB34 Cash Flow Statement

Cash Flow/Share TTM 7.4
Revenue/Share TTM 23.4
Operating Cash Flow  24.70%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5591 2326 2834 4252
Cash From Investing Activities -219 -1319 -19618 -1346
Cash From Financing Activities -3852 -4023 14644 967
Net Change in Cash 1597 -3038 -2185 3951
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMYB34 Comments

Write your thoughts about Bristol-Myers Squibb Company BDR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email